EDELRIS is a medicinal chemistry company dedicated to the design and synthesis of innovative, natural product-mimetic screening compounds, Hit-to-Lead & Lead Optimization projects and Custom Synthesis.
Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its validated chemistry and drug discovery expertise to provide novelty to its customers with exclusive or non-exclusive small molecules and with efficient hit-to-lead optimization capabilities.
Browse our website or contact us for further information
2013-02-07
EDELRIS selected as a partner of the European Lead Factory
2013-06-02 / 2013-06-07
Edelris will be attending the GRC "High Throughput Chemistry and Chemical Biology" in New London NH, US
2013-07-02 / 2013-07-05
Edelris will be attenting the RICT 2013 in Nice, France
